BlackRock’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295M | Sell |
|
|||||
|
2025
Q1 | $317M | Sell |
|
|||||
|
2024
Q4 | $362M | Sell |
|
|||||
|
2024
Q3 | $314M | Sell |
|
|||||
|
2024
Q2 | $278M | Buy |
|
|||||
|
2024
Q1 | $353M | Sell |
|
|||||
|
2023
Q4 | $300M | Buy |
|
|||||
|
2023
Q3 | $281M | Buy |
|
|||||
|
2023
Q2 | $299M | Buy |
|
|||||
|
2023
Q1 | $344M | Sell |
|
|||||
|
2022
Q4 | $343M | Buy |
|
|||||
|
2022
Q3 | $312M | Buy |
|
|||||
|
2022
Q2 | $254M | Sell |
|
|||||
|
2022
Q1 | $287M | Buy |
|
|||||
|
2021
Q4 | $246M | Sell |
|
|||||
|
2021
Q3 | $236M | Sell |
|
|||||
|
2021
Q2 | $273M | Sell |
|
|||||
|
2021
Q1 | $235M | Buy |
|
|||||
|
2020
Q4 | $224M | Sell |
|
|||||
|
2020
Q3 | $189M | Buy |
|
|||||
|
2020
Q2 | $211M | Buy |
|
|||||
|
2020
Q1 | $154M | Sell |
|
|||||
|
2019
Q4 | $207M | Buy |
|
|||||
|
2019
Q3 | $228M | Buy |
|
|||||
|
2019
Q2 | $271M | Buy |
|
|||||
|
2019
Q1 | $282M | Sell |
|
|||||
|
2018
Q4 | $268M | Buy |
|
|||||
|
2018
Q3 | $403M | Buy |
|
|||||
|
2018
Q2 | $460M | Buy |
|
|||||
|
2018
Q1 | $324M | Buy |
|
|||||
|
2017
Q4 | $275M | Buy |
|
|||||
|
2017
Q3 | $271M | Buy |
|
|||||
|
2017
Q2 | $290M | Buy |
|
|||||
|
2017
Q1 | $210M | Buy |
|
|||||
|
2016
Q4 | $109K | Sell |
|
|||||
|
2016
Q3 | $116K | Sell |
|
|||||
|
2016
Q2 | $97K | Buy |
|
|||||
|
2016
Q1 | $39K | Buy |
|
|||||
|
2015
Q4 | $14K | Buy |
|
|||||
|
2015
Q3 | $9K | Hold |
|
|||||
|
2015
Q2 | $11K | Sell |
|
|||||
|
2015
Q1 | $9K | Hold |
|
|||||
|
2014
Q4 | $6K | Hold |
|
|||||
|
2014
Q3 | $7K | Hold |
|
|||||
|
2014
Q2 | $8K | Buy |
|